These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 35967359)

  • 21. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.
    Distler E; Schnürer E; Wagner E; von Auer C; Plachter B; Wehler D; Huber C; Kolbe K; Meyer RG; Herr W
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1417-24. PubMed ID: 19041065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between cell-mediated immunity to Varicella-Zoster virus and aging in subjects from the community-based Shozu Herpes Zoster study.
    Shirane R; Tang H; Hayashi K; Okuno Y; Iso H; Asada H; Yamanishi K; Mori Y;
    J Med Virol; 2017 Feb; 89(2):313-317. PubMed ID: 27420414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subsets of T-cells and in vitro cytokine production after measles and varicellae-zoster virus antigen stimulation in allogeneic BMT patients.
    Pauksen K; Sjölin J; Linde A; Andersson B; Lenkei R; Oberg G; Ljungman P
    Scand J Infect Dis; 1999; 31(1):43-9. PubMed ID: 10381217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
    Anderson TC; Masters NB; Guo A; Shepersky L; Leidner AJ; Lee GM; Kotton CN; Dooling KL
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(3):80-84. PubMed ID: 35051134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantation.
    Baumrin E; Izaguirre NE; Bausk B; Feeley MM; Bay CP; Yang Q; Ho VT; Baden LR; Issa NC
    Blood Adv; 2021 Mar; 5(6):1585-1593. PubMed ID: 33710336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial.
    Bastidas A; de la Serna J; El Idrissi M; Oostvogels L; Quittet P; López-Jiménez J; Vural F; Pohlreich D; Zuckerman T; Issa NC; Gaidano G; Lee JJ; Abhyankar S; Solano C; Perez de Oteyza J; Satlin MJ; Schwartz S; Campins M; Rocci A; Vallejo Llamas C; Lee DG; Tan SM; Johnston AM; Grigg A; Boeckh MJ; Campora L; Lopez-Fauqued M; Heineman TC; Stadtmauer EA; Sullivan KM;
    JAMA; 2019 Jul; 322(2):123-133. PubMed ID: 31287523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VaccHemInf project: protocol for a prospective cohort study of efficacy, safety and characterisation of immune functional response to vaccinations in haematopoietic stem cell transplant recipients.
    Conrad A; Boccard M; Valour F; Alcazer V; Tovar Sanchez AT; Chidiac C; Laurent F; Vanhems P; Salles G; Brengel-Pesce K; Meunier B; Trouillet-Assant S; Ader F;
    BMJ Open; 2019 Feb; 9(2):e026093. PubMed ID: 30772864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Varicella-zoster virus-specific cell-mediated immunity by interferon-γ Enzyme-Linked Immunosorbent Assay in adults ≥50 years of age administered a herpes zoster vaccine.
    Yang P; Chen Z; Zhang J; Li W; Zhu C; Qiu P; Quan Y; Cui X; Yuan L; Jiang C
    J Med Virol; 2019 May; 91(5):829-835. PubMed ID: 30613990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunobiology of Varicella-Zoster Virus Infection.
    Laing KJ; Ouwendijk WJD; Koelle DM; Verjans GMGM
    J Infect Dis; 2018 Sep; 218(suppl_2):S68-S74. PubMed ID: 30247598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zoster prophylaxis after allogeneic hematopoietic cell transplantation using acyclovir/valacyclovir followed by vaccination.
    Jamani K; MacDonald J; Lavoie M; Williamson TS; Brown CB; Chaudhry A; Jimenez-Zepeda VH; Duggan P; Tay J; Stewart D; Daly A; Storek J
    Blood Adv; 2016 Dec; 1(2):152-159. PubMed ID: 29296807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.
    Ogonek J; Kralj Juric M; Ghimire S; Varanasi PR; Holler E; Greinix H; Weissinger E
    Front Immunol; 2016; 7():507. PubMed ID: 27909435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
    Arber DA; Orazi A; Hasserjian R; Thiele J; Borowitz MJ; Le Beau MM; Bloomfield CD; Cazzola M; Vardiman JW
    Blood; 2016 May; 127(20):2391-405. PubMed ID: 27069254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
    Swerdlow SH; Campo E; Pileri SA; Harris NL; Stein H; Siebert R; Advani R; Ghielmini M; Salles GA; Zelenetz AD; Jaffe ES
    Blood; 2016 May; 127(20):2375-90. PubMed ID: 26980727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses.
    Jing L; Laing KJ; Dong L; Russell RM; Barlow RS; Haas JG; Ramchandani MS; Johnston C; Buus S; Redwood AJ; White KD; Mallal SA; Phillips EJ; Posavad CM; Wald A; Koelle DM
    J Immunol; 2016 Mar; 196(5):2205-2218. PubMed ID: 26810224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay.
    Hayashida K; Ozaki T; Nishimura N; Gotoh K; Funahashi K; Nakane K; Gomi Y; Manabe S; Ishikawa T; Yamanishi K
    J Immunol Methods; 2015 Nov; 426():50-5. PubMed ID: 26232696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of CMV-specific CD4+ T-cell reconstitution following stem cell transplantation through the use of HLA Class II-peptide tetramers identifies patients at high risk of recurrent CMV reactivation.
    Raeiszadeh M; Pachnio A; Begum J; Craddock C; Moss P; Chen FE
    Haematologica; 2015 Aug; 100(8):e318-22. PubMed ID: 25975839
    [No Abstract]   [Full Text] [Related]  

  • 37. Flow cytometric evaluation of lymphocyte transformation test based on 5-ethynyl-2'deoxyuridine incorporation as a clinical alternative to tritiated thymidine uptake measurement.
    Poujol F; Monneret G; Friggeri A; Rimmelé T; Malcus C; Poitevin-Later F; Pachot A; Lepape A; Textoris J; Venet F
    J Immunol Methods; 2014 Dec; 415():71-9. PubMed ID: 25450005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Varicella-zoster virus-specific, cell-mediated immunity with interferon-gamma release assay after vaccination of college students with no or intermediate IgG antibody response.
    Terada K; Itoh Y; Fujii A; Kitagawa S; Ogita S; Ouchi K
    J Med Virol; 2015 Feb; 87(2):350-6. PubMed ID: 25080078
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.